Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in the United States. The company is advancing respiratory and cancer treatments using its proprietary Anticalin platform. Pieris has developed 4-1BB bispecific programs that have been partnered with pharmaceutical companies, providing the potential for future milestones and royalties.